• Home
  • >
  • Alkem Laboratories Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/alkem-laboratories-ltd.png Logo

Alkem Laboratories Ltd Financial Statement

Alkem Laboratories Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Dec 2023Sep 2023Jun 2023
Revenue2,590.252,696.432,317.87
Operating Expense1,976.641,979.991,919.42
Net Profit504.23646.51271.44
Net Profit Margin19.4723.9811.71
Earning Per Share42.1754.0722.7
EBIDTA673.92835.71404.9
Effective Tax Rate14.7415.5613.53

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Alkem Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual11,599.2610,634.198,865.01
Operating Expenses Annual9,989.818,581.276,922.62
Operating Profit Annual1,722.552,200.612,175.6
Interest Annual107.3652.3758.92
Depreciation310.42303.96224.06
Net Profit Annual984.171,645.621,585.02
Tax Annual297.96163.96224.33

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Alkem Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning232.18174.22175.94
Cash Flow from Operations1,682.51,111.021,264.9
Cash Flow from Investing119.94-1,432.63-994.87
Cash Flow from Financing-1,760.82379.57-271.75
Cash Flow at the End273.8232.18174.22

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Alkem Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)14.8520.6924.54
PBIT Margin (%)12.1717.8421.44
PBT Margin (%)12.0217.4320.99
Net PROFIT Margin (%)12.5317.4623.34
Return On Networth / Equity (%)11.3920.9823.9
Return On Networth /Employed(%)12.481821.7
Return On Assets (%)12.5317.2823.11
Total Debt / Equity(X)0.190.220.19
Asset Turnover Ratio (%)10.990.99

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Alkem Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual2,695.82,901.732,792.98
Total Current Assets Annual8,729.78,435.436,923.27
Non Current Assets Annual5,026.955,633.764,590.44
Total Shareholders Funds Annual9,045.298,637.97,376.73
Total Assets Annual13,756.6514,069.1911,519.26

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Alkem Laboratories Ltd Earning Calls
Dec 2023
EPS beaten by -0.02 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Alkem Laboratories Ltd has a market capitalization of 40,626.39 Cr. Value Research classifies it as a Large-Cap company.

Yes, Alkem Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.17.

In FY 2023, Alkem Laboratories Ltd recorded a total revenue of approximately 11,599.26 Cr marking a significant milestone in the company's financial performance.

Alkem Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and 0.1% annually, respectively..

Alkem Laboratories Ltd's current PE ratio is 41.28.

Alkem Laboratories Ltd's ROCE averaged 16.9% from the FY ending March 2021 to 2023, with a median of 16.8%. It peaked at 20.7% in March 2021, reflecting strong capital efficiency over the period..

Alkem Laboratories Ltd's latest EBIT is Rs. 1,412.13 Cr, surpassing the average EBIT of Rs. 1,736.6 Cr over the 5 years..